• 1. Examination of ammonia–poly(pyrrole) interactions by piezoelectric and conductivity measurements
  Analyst, 1991,116, 1125-1130
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Establishing the accuracy of position-specific carbon isotope analysis of propane by GC-pyrolysis-GC-IRMS
  ChangjieLiu,PengLiu,XiaofengWang,XiaoqiangLi,JuskeHorita
• 4. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 5. Elusive 2-aminofuran Diels–Alder substrates for a straightforward synthesis of polysubstituted anilines?
  Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555

Ethanone, 1-(3-fluorophenyl)-2-(4-pyridinyl)- (CAS No: 6576-04-1): A Comprehensive Overview

Ethanone, 1-(3-fluorophenyl)-2-(4-pyridinyl)-, identified by its CAS number 6576-04-1, is a significant compound in the realm of chemical and pharmaceutical research. This heterocyclic ketone has garnered considerable attention due to its unique structural properties and potential applications in medicinal chemistry. The compound's molecular structure, featuring a fluorophenyl group and a pyridinyl moiety, makes it a promising candidate for further exploration in drug development.

The synthesis of Ethanone, 1-(3-fluorophenyl)-2-(4-pyridinyl)-, involves intricate organic transformations that highlight the compound's complexity. The presence of both fluorine and pyridine substituents contributes to its distinct chemical behavior, enabling diverse interactions with biological targets. This compound's versatility has been exploited in various research settings, particularly in the design of novel therapeutic agents.

In recent years, Ethanone, 1-(3-fluorophenyl)-2-(4-pyridinyl)-, has been the subject of numerous studies aimed at elucidating its pharmacological properties. Researchers have been particularly interested in its potential as an intermediate in the synthesis of small-molecule drugs. The compound's ability to act as a scaffold for medicinal chemistry has led to the development of several derivatives with enhanced biological activity.

One of the most intriguing aspects of this compound is its role in the development of kinase inhibitors. Kinases are enzymes that play a crucial role in cell signaling pathways, and their dysregulation is often associated with various diseases, including cancer. By targeting kinases, researchers aim to develop treatments that can modulate these pathways effectively. Ethanone, 1-(3-fluorophenyl)-2-(4-pyridinyl)-, has shown promise as a key intermediate in the synthesis of such inhibitors.

The incorporation of fluorine into the molecular structure of Ethanone, 1-(3-fluorophenyl)-2-(4-pyridinyl)-, enhances its metabolic stability and binding affinity to biological targets. Fluorinated compounds are well-known for their improved pharmacokinetic properties, which make them more suitable for therapeutic applications. This feature has made this compound an attractive choice for drug discovery programs.

Recent advancements in computational chemistry have further facilitated the study of Ethanone, 1-(3-fluorophenyl)-2-(4-pyridinyl)-. Molecular modeling techniques have allowed researchers to predict the binding modes of this compound with various protein targets with high accuracy. These predictions have guided the design of more effective derivatives with optimized pharmacological profiles.

The use of Ethanone, 1-(3-fluorophenyl)-2-(4-pyridinyl)-, as a building block for drug development has also led to significant breakthroughs in personalized medicine. By understanding how individual patients respond to different chemical structures, researchers can tailor treatments to specific genetic profiles. This approach has the potential to revolutionize healthcare by providing more targeted and effective therapies.

In conclusion, Ethanone, 1-(3-fluorophenyl)-2-(4-pyridinyl)- (CAS No: 6576-04-1), is a multifaceted compound with substantial potential in pharmaceutical research. Its unique structural features and biological activities make it a valuable tool for developing novel therapeutic agents. As research continues to uncover new applications for this compound, its significance in medicinal chemistry is likely to grow even further.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)